Mediar Therapeutics, Inc.

Biotechnology company · Boston, Massachusetts, United States

Mediar Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $38 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Mediar Therapeutics at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2018

SEC CIK1766784

What does Mediar Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $37.8 million sold (2025).

Frequently asked questions about Mediar Therapeutics

Where is Mediar Therapeutics headquartered?

Mediar Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Mediar Therapeutics do?

Mediar Therapeutics, Inc. is a biotechnology company.

When was Mediar Therapeutics founded?

The earliest incorporation on record for Mediar Therapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences